Form 4: Q32 Bio Inc. Executive Charles Michaud Jr. Reports Beneficial Ownership Changes Following Merger
SEC Form 4 Filing
Charles Michaud Jr., Vice President, Corporate Controller and Treasurer of Q32 Bio Inc., reports changes in beneficial ownership of common stock and restricted stock units following the merger with Kenobi Merger Sub, Inc.
Summary
- On March 25, 2024, Charles Michaud Jr., an officer of Q32 Bio Inc., reported changes in his beneficial ownership of the company's securities.
- These changes are related to the merger agreement between Q32 Bio Inc., Kenobi Merger Sub, Inc., and Q32 Bio Inc. dated November 16, 2023.
- Michaud disposed of 6,448 shares of common stock.
- He also had 1,088 and 5,360 Restricted Stock Units (RSUs) vest in full on March 25, 2024, immediately prior to the effective time of the merger.
- Following these transactions, Michaud beneficially owns 18,046 shares of common stock and no Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to a merger, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice when company insiders trade securities, providing transparency to the market.
Stakeholder Impact
- Shareholders are informed about changes in insider ownership due to the merger.
Key Dates
| Date | Description |
|---|---|
| 2023/11/16 | Date of the Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. |
| 2024/03/25 | Date of the earliest transaction and vesting of RSUs. |
| 2024/03/27 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.